Hormone Therapy Enhances Tirzepatide Weight Loss
Concurrent menopausal hormone therapy increases tirzepatide efficacy in postmenopausal women
In a retrospective cohort of 400 postmenopausal women on tirzepatide, those receiving menopausal hormone therapy achieved 35 % greater total body weight loss and were 2.5 times more likely to hit ≥ 20 % weight reduction compared with women on tirzepatide alone.
Study Details
Postmenopausal status is associated with reduced response to GLP-1 and dual GIP/G…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.